Sign in
DMPWW Stock Price, Chart, Stats & News
DelMar Pharmaceuticals, Inc.
Save
DelMar Pharmaceuticals, Inc. (DMPWW) does not currently pay a dividend.
232,279
Market cap
–
Current P/E
–
Forward P/E
DMPWW chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Kintara Therapeutics, Inc., previously known as DelMar Pharmaceuticals, Inc. until its rebranding in August 2020, operates as a clinical-stage pharmaceutical firm. Headquartered in San Diego, California, and established in 2009, the company is committed to advancing and bringing to market anti-cancer treatments for patients. Its development pipeline includes two advanced therapeutic candidates.
Similar securities
Based on sector and market capitalization
Report issue